Apraclonidine is a medication classified as an alpha-2 adrenergic agonist [1]. It is primarily used to lower intraocular pressure (IOP) in the eye [2].
How does apraclonidine work to lower eye pressure?
Apraclonidine functions by reducing the production of aqueous humor within the eye and increasing its outflow [3]. This dual action helps to decrease the overall pressure inside the eyeball.
What conditions is apraclonidine prescribed for?
Apraclonidine is typically prescribed to manage elevated intraocular pressure, particularly following laser surgery, such as iridotomy or trabeculoplasty [2]. It may also be used in patients with chronic open-angle glaucoma, though other agents are often preferred for long-term management [4].
Are there different strengths or formulations of apraclonidine?
Apraclonidine is available as an ophthalmic solution, commonly in a 0.5% concentration [1][2].
What are the potential side effects of apraclonidine?
Common side effects include stinging or burning upon application, blurred vision, dryness of the mouth, and headache [2]. Less common side effects can involve allergic reactions, eyelid reactions, and changes in heart rate [2].
How does apraclonidine compare to other glaucoma medications?
Compared to other alpha-2 agonists like brimonidine, apraclonidine has a shorter duration of action and is generally considered less potent for long-term glaucoma control [4]. It is often favored for short-term use around laser procedures due to its rapid onset of action and fewer systemic side effects compared to older medications [4].
What is the patent status of apraclonidine?
As apraclonidine is an older medication, its primary patents have long expired. Information on specific patent expirations and market exclusivity for branded formulations can be found through resources like DrugPatentWatch.com [5].
Can generic versions of apraclonidine be produced?
Yes, due to the expiration of its original patents, generic versions of apraclonidine eye drops are available [5].
Who manufactures apraclonidine?
Original branded formulations have been marketed by companies like Alcon. Generic versions are produced by various pharmaceutical manufacturers [5].
Sources:
[1] https://www.drugpatentwatch.com/brands/apraclonidine
[2] https://www.ncbi.nlm.nih.gov/books/NBK532923/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512065/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918611/
[5] https://www.drugpatentwatch.com/